KR20210045529A - Method for preparing fermentated ziziphus jujuba seed - Google Patents
Method for preparing fermentated ziziphus jujuba seed Download PDFInfo
- Publication number
- KR20210045529A KR20210045529A KR1020190127803A KR20190127803A KR20210045529A KR 20210045529 A KR20210045529 A KR 20210045529A KR 1020190127803 A KR1020190127803 A KR 1020190127803A KR 20190127803 A KR20190127803 A KR 20190127803A KR 20210045529 A KR20210045529 A KR 20210045529A
- Authority
- KR
- South Korea
- Prior art keywords
- fermented
- jujube
- seeds
- jujube seed
- seed
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 23
- 240000000038 Ziziphus mauritiana Species 0.000 title abstract 8
- 235000006545 Ziziphus mauritiana Nutrition 0.000 title abstract 8
- 235000008529 Ziziphus vulgaris Nutrition 0.000 title abstract 8
- 238000000855 fermentation Methods 0.000 claims abstract description 25
- 230000004151 fermentation Effects 0.000 claims abstract description 25
- 239000000843 powder Substances 0.000 claims abstract description 21
- 230000001954 sterilising effect Effects 0.000 claims abstract description 21
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 10
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 10
- 244000063299 Bacillus subtilis Species 0.000 claims abstract description 8
- 235000014469 Bacillus subtilis Nutrition 0.000 claims abstract description 8
- 241000894006 Bacteria Species 0.000 claims abstract description 7
- 239000012535 impurity Substances 0.000 claims abstract description 7
- 238000010298 pulverizing process Methods 0.000 claims abstract description 6
- 239000004310 lactic acid Substances 0.000 claims abstract description 5
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 5
- 238000004519 manufacturing process Methods 0.000 claims description 21
- 238000004659 sterilization and disinfection Methods 0.000 claims description 14
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 9
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 9
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 6
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 6
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 238000012258 culturing Methods 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 3
- 238000007602 hot air drying Methods 0.000 claims description 3
- 238000003860 storage Methods 0.000 claims description 3
- 241000192132 Leuconostoc Species 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 238000000227 grinding Methods 0.000 claims description 2
- 241001247821 Ziziphus Species 0.000 claims 10
- 239000006227 byproduct Substances 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 3
- 244000126002 Ziziphus vulgaris Species 0.000 description 108
- 230000000694 effects Effects 0.000 description 37
- 210000003491 skin Anatomy 0.000 description 37
- 239000000523 sample Substances 0.000 description 31
- 230000002401 inhibitory effect Effects 0.000 description 29
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 28
- 239000000203 mixture Substances 0.000 description 24
- 210000004027 cell Anatomy 0.000 description 21
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 19
- 235000013305 food Nutrition 0.000 description 17
- 102000003425 Tyrosinase Human genes 0.000 description 16
- 108060008724 Tyrosinase Proteins 0.000 description 16
- 230000000052 comparative effect Effects 0.000 description 16
- 239000002537 cosmetic Substances 0.000 description 14
- 102000008186 Collagen Human genes 0.000 description 13
- 108010035532 Collagen Proteins 0.000 description 13
- 229920001436 collagen Polymers 0.000 description 13
- 239000000047 product Substances 0.000 description 12
- 239000000243 solution Substances 0.000 description 11
- 230000037303 wrinkles Effects 0.000 description 11
- 102000029816 Collagenase Human genes 0.000 description 10
- 108060005980 Collagenase Proteins 0.000 description 10
- 229960000271 arbutin Drugs 0.000 description 10
- 235000013376 functional food Nutrition 0.000 description 10
- 239000002609 medium Substances 0.000 description 10
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 10
- 230000002292 Radical scavenging effect Effects 0.000 description 9
- 235000013361 beverage Nutrition 0.000 description 9
- 238000009472 formulation Methods 0.000 description 9
- 230000008099 melanin synthesis Effects 0.000 description 9
- 102000016942 Elastin Human genes 0.000 description 8
- 108010014258 Elastin Proteins 0.000 description 8
- 238000002835 absorbance Methods 0.000 description 8
- 239000004480 active ingredient Substances 0.000 description 8
- 229960002424 collagenase Drugs 0.000 description 8
- 229920002549 elastin Polymers 0.000 description 8
- 230000006872 improvement Effects 0.000 description 8
- 239000008194 pharmaceutical composition Substances 0.000 description 8
- 239000011535 reaction buffer Substances 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 230000002087 whitening effect Effects 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 7
- 230000002849 elastaseinhibitory effect Effects 0.000 description 7
- 229940088598 enzyme Drugs 0.000 description 7
- 229930003935 flavonoid Natural products 0.000 description 7
- 150000002215 flavonoids Chemical class 0.000 description 7
- 235000017173 flavonoids Nutrition 0.000 description 7
- -1 glycerol aliphatic ester Chemical class 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 5
- 241000192130 Leuconostoc mesenteroides Species 0.000 description 5
- 102000016387 Pancreatic elastase Human genes 0.000 description 5
- 108010067372 Pancreatic elastase Proteins 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 235000013373 food additive Nutrition 0.000 description 5
- 239000002778 food additive Substances 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 230000036564 melanin content Effects 0.000 description 5
- 150000008442 polyphenolic compounds Chemical class 0.000 description 5
- 235000013824 polyphenols Nutrition 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 4
- 102400000740 Melanocyte-stimulating hormone alpha Human genes 0.000 description 4
- 101710200814 Melanotropin alpha Proteins 0.000 description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 4
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 210000002615 epidermis Anatomy 0.000 description 4
- 239000000469 ethanolic extract Substances 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000013355 food flavoring agent Nutrition 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000014509 gene expression Effects 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 4
- 239000012224 working solution Substances 0.000 description 4
- WHNFPRLDDSXQCL-UAZQEYIDSA-N α-msh Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(N)=O)NC(=O)[C@H](CO)NC(C)=O)C1=CC=C(O)C=C1 WHNFPRLDDSXQCL-UAZQEYIDSA-N 0.000 description 4
- 238000002965 ELISA Methods 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 230000003796 beauty Effects 0.000 description 3
- 230000000903 blocking effect Effects 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 239000003937 drug carrier Substances 0.000 description 3
- 210000004177 elastic tissue Anatomy 0.000 description 3
- 235000020510 functional beverage Nutrition 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 210000002752 melanocyte Anatomy 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000009759 skin aging Effects 0.000 description 3
- 230000037394 skin elasticity Effects 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 235000012222 talc Nutrition 0.000 description 3
- 235000013311 vegetables Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 2
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 229940122858 Elastase inhibitor Drugs 0.000 description 2
- 206010014970 Ephelides Diseases 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 229960005305 adenosine Drugs 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 238000003149 assay kit Methods 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000000378 calcium silicate Substances 0.000 description 2
- 229910052918 calcium silicate Inorganic materials 0.000 description 2
- 235000012241 calcium silicate Nutrition 0.000 description 2
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 235000013351 cheese Nutrition 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000003602 elastase inhibitor Substances 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 235000011194 food seasoning agent Nutrition 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- 235000021109 kimchi Nutrition 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000006872 mrs medium Substances 0.000 description 2
- 235000012149 noodles Nutrition 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 229940124595 oriental medicine Drugs 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 235000021110 pickles Nutrition 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 235000021067 refined food Nutrition 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 235000015067 sauces Nutrition 0.000 description 2
- 230000002000 scavenging effect Effects 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 230000035899 viability Effects 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 230000037373 wrinkle formation Effects 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- APRZHQXAAWPYHS-UHFFFAOYSA-N 4-[5-[3-(carboxymethoxy)phenyl]-3-(4,5-dimethyl-1,3-thiazol-2-yl)tetrazol-3-ium-2-yl]benzenesulfonate Chemical compound S1C(C)=C(C)N=C1[N+]1=NC(C=2C=C(OCC(O)=O)C=CC=2)=NN1C1=CC=C(S([O-])(=O)=O)C=C1 APRZHQXAAWPYHS-UHFFFAOYSA-N 0.000 description 1
- TVEXGJYMHHTVKP-UHFFFAOYSA-N 6-oxabicyclo[3.2.1]oct-3-en-7-one Chemical compound C1C2C(=O)OC1C=CC2 TVEXGJYMHHTVKP-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 238000010269 ABTS assay Methods 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 235000006491 Acacia senegal Nutrition 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 235000007862 Capsicum baccatum Nutrition 0.000 description 1
- 241000195628 Chlorophyta Species 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- AHMIDUVKSGCHAU-UHFFFAOYSA-N Dopaquinone Natural products OC(=O)C(N)CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-UHFFFAOYSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 102000013382 Gelatinases Human genes 0.000 description 1
- 108010026132 Gelatinases Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 108060003393 Granulin Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
- AHMIDUVKSGCHAU-LURJTMIESA-N L-dopaquinone Chemical compound [O-]C(=O)[C@@H]([NH3+])CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-LURJTMIESA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- VHLJDTBGULNCGF-UHFFFAOYSA-N Limonin Natural products CC1(C)OC2CC(=O)OCC23C4CCC5(C)C(CC(=O)C6OC56C4(C)C(=O)CC13)c7cocc7 VHLJDTBGULNCGF-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 1
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- IKMDFBPHZNJCSN-UHFFFAOYSA-N Myricetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC(O)=C(O)C(O)=C1 IKMDFBPHZNJCSN-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 206010040865 Skin hyperpigmentation Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 235000015434 Ziziphus jujuba var spinosa Nutrition 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 1
- 235000008714 apigenin Nutrition 0.000 description 1
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 1
- 229940117893 apigenin Drugs 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 235000008452 baby food Nutrition 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000012496 blank sample Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 239000001728 capsicum frutescens Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000008004 cell lysis buffer Substances 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000005827 chlorofluoro hydrocarbons Chemical class 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 230000037319 collagen production Effects 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 235000019985 fermented beverage Nutrition 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 1
- 150000007946 flavonol Chemical class 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- KBDSLGBFQAGHBE-MSGMIQHVSA-N limonin Chemical compound C=1([C@H]2[C@]3(C)CC[C@H]4[C@@]([C@@]53O[C@@H]5C(=O)O2)(C)C(=O)C[C@@H]2[C@]34COC(=O)C[C@@H]3OC2(C)C)C=COC=1 KBDSLGBFQAGHBE-MSGMIQHVSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 230000003061 melanogenesis Effects 0.000 description 1
- 210000002780 melanosome Anatomy 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- PCOBUQBNVYZTBU-UHFFFAOYSA-N myricetin Natural products OC1=C(O)C(O)=CC(C=2OC3=CC(O)=C(O)C(O)=C3C(=O)C=2)=C1 PCOBUQBNVYZTBU-UHFFFAOYSA-N 0.000 description 1
- 235000007743 myricetin Nutrition 0.000 description 1
- 229940116852 myricetin Drugs 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 150000004633 phorbol derivatives Chemical class 0.000 description 1
- 239000002644 phorbol ester Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- 239000001965 potato dextrose agar Substances 0.000 description 1
- 235000020991 processed meat Nutrition 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000009790 rate-determining step (RDS) Methods 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000004215 skin function Effects 0.000 description 1
- 208000031019 skin pigmentation disease Diseases 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000013322 soy milk Nutrition 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- WHNFPRLDDSXQCL-UHFFFAOYSA-N α-melanotropin Chemical compound C=1N=CNC=1CC(C(=O)NC(CC=1C=CC=CC=1)C(=O)NC(CCCNC(N)=N)C(=O)NC(CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)NC(CCCCN)C(=O)N1C(CCC1)C(=O)NC(C(C)C)C(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(CCSC)NC(=O)C(CO)NC(=O)C(NC(=O)C(CO)NC(C)=O)CC1=CC=C(O)C=C1 WHNFPRLDDSXQCL-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/01—Instant products; Powders; Flakes; Granules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/10—Drying, dehydrating
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/31—Leuconostoc
- A23V2400/321—Mesenteroides
-
- A23Y2220/67—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
Description
본 출원은 대추씨 발효물을 제조하는 방법에 관한 것이다. The present application relates to a method of manufacturing a fermented jujube seed.
대추씨는 대추의 과육 안에 있는 종자부위로써 대추 과육의 가공 후 생성되는 대추 가공 부산물이다. 대추 가공 시 생산되는 대추씨 부산물은 대추가공원료의 약 30% 중량을 차지한다. 예로부터 대추는 한방에서 감초 처럼 감미를 내기 위해 첨가되는 경우가 많았고 그 자체로도 위경련, 불면증, 소화불량, 대장하혈, 청혈, 지각 과민증의 증상을 개선시키는 약리효과가 있다. 대추씨는 단백질, 미네랄, 식이섬유 등의 함량이 높아 영양학적인 가치가 높고 한방에서는 산조인이라는 약재로도 사용되어져 왔다. 이러한 우수한 영양 및 약리학적인 가치에도 불구하고 대부분의 대추씨 자원은 산업적으로 활용되지 못하고 한국에서 연간 2통 이상이 폐기되는 실정이다. Jujube seeds are the seed parts in the pulp of jujube and are a by-product of jujube processing produced after processing the jujube pulp. Jujube seed by-products produced during jujube processing account for about 30% by weight of jujube park materials. Since ancient times, jujube has been added to give sweetness like licorice in oriental medicine, and itself has a pharmacological effect that improves the symptoms of stomach cramps, insomnia, indigestion, sub large intestine blood, red blood, and hypersensitivity. Jujube seeds have high nutritional value due to their high content of protein, minerals, and dietary fiber, and have been used as a medicinal ingredient called Sanjoin in oriental medicine. Despite these excellent nutritional and pharmacological values, most of the jujube seed resources are not utilized industrially, and more than two barrels per year are discarded in Korea.
사람의 피부색은 피부 내부의 멜라닌(melanin) 농도와 분포에 따라 결정되는데, 유전적인 요인 외에도, 태양 자외선이나 피로, 스트레스 등의 환경적 또는 생리적 조건에 의해서도 영향을 받는다. 멜라닌은 피부 표피 층에 있는 멜라노사이트에서 합성되는데, 멜라노사이트 내 소기관인 멜라노좀(melanosome)에서 아미노산의 일종인 티로신(tyrosine)에 티로시나제(tyrosinase)라는 효소가 작용하여 도파(DOPA), 도파퀴논(dopaquinone)으로 바뀐 후 비효소적인 산화반응을 거쳐 만들어진다. 이와 같은 멜라닌의 합성이 피부 내에서 과도하게 일어나면, 피부 톤을 어둡게 하고, 기미, 주근깨 등을 발생시킨다. 따라서, 피부 내의 티로시나제 활성을 저해하여 멜라닌 색소의 합성을 저해시키면, 피부 톤을 밝게 하여 피부 미백을 실현할 수 있을뿐만 아니라 자외선, 호르몬 및 유전적인 원인에 기인하여 발생하는 기미, 주근깨 등의 피부 과색소 침착증을 개선시킬 수 있다. 시키고, 멜라닌 자체가 자유라디칼의 성질을 나타내기도 한다.Human skin color is determined by the concentration and distribution of melanin inside the skin. In addition to genetic factors, it is affected by environmental or physiological conditions such as solar ultraviolet rays, fatigue, and stress. Melanin is synthesized from melanocytes in the epidermal layer of the skin, and an enzyme called tyrosinase acts on tyrosine, a kind of amino acid, in the melanosome, an organelle within the melanocyte. dopaquinone) and then made through a non-enzymatic oxidation reaction. When such melanin synthesis occurs excessively in the skin, it darkens the skin tone and causes spots, freckles, and the like. Therefore, by inhibiting the synthesis of melanin pigment by inhibiting the tyrosinase activity in the skin, it is possible to realize skin whitening by brightening the skin tone, as well as skin hyperpigmentation such as spots and freckles caused by ultraviolet rays, hormones and genetic causes. It can improve calmness. In addition, melanin itself also exhibits the properties of free radicals.
피부는 노화가 일차적으로 나타나는 기관으로 이를 지연 또는 예방하기 위하여 화장품 영역에서도 많은 연구가 진행되어 왔다. 피부 노화의 대표적 현상으로 피지 분비량이 감소되어 피부가 건조해지고, 세포 재생이 늦어지고, 노화 각질이 많이 쌓여서 피부가 거칠어지는 특징이 있다. 또한, 표피를 지탱해주는 콜라겐의 합성 양이 감소되고 엘라스틴(탄력섬유)이 변성되어 주름이 생긴다. 아울러, 피부색이 얼룩지거나 기미, 검버섯 등 의 색소 침착 증상이 나타나며, 표피가 얇아져서 피부보호 기능이 약화된다. 그 밖의 현상으로는 피부 두께의 감소와 관련된 피부 장벽작용(Barrier Effect)의 저하로 인한 피부 트러블의 증가를 들 수 있다. 피부노화와 관련된 연구는 크게 피부노화의 주요원인이 되는 자외선과 활성산소로부터 피부를 보호하는 소재, 피부주름 개선 소재, 피부탄력 증진 소재, 피부 표피와 진피 접합부(Dermal-Epidermal Junction, DEJ) 강화에 관련된 소재 로 분류하여 심도 깊게 연구되고 있다.Skin is an organ where aging occurs primarily, and in order to delay or prevent it, many studies have also been conducted in the cosmetic field. As a representative phenomenon of skin aging, the amount of sebum secretion is reduced, resulting in dry skin, slow cell regeneration, and a lot of aging dead skin cells accumulating, resulting in rough skin. In addition, the amount of collagen synthesis that supports the epidermis is reduced, and elastin (elastic fibers) is denatured, resulting in wrinkles. In addition, the skin color is stained, spots, and pigmentation symptoms such as age spots appear, and the skin protection function is weakened due to the thinning of the epidermis. Other phenomena include an increase in skin troubles due to a decrease in the skin barrier effect associated with a decrease in skin thickness. Research related to skin aging has been largely focused on materials that protect the skin from ultraviolet rays and free radicals, which are the main causes of skin aging, materials for improving skin wrinkles, materials for enhancing skin elasticity, and strengthening the skin epidermis and dermal junction (DEJ). It is classified into related materials and is being studied in depth.
피부에 노화가 진행되면 진피의 변화가 현저하게 나타나며, 진피의 변화는 섬유아세포(fibroblast)의 숫자와 이들의 합성 능력의 감소로 인하여 세포 외 기질 중 큰 분자량을 가진 물질들의 변화로 발생된다. 그 구체적인 변화는 콜라겐 다발의 분리, 점다당질 합성감소, 콜라겐과 탄력섬유(elastin) 수와 직경 감소, 콜라겐과 탄력섬유 분해 및 혈관의 팽창 등을 들 수 있다. 일반적으로 피부의 수분 함유량, 콜라겐 함유량 및 외부 환경에 대한 면역 작용 능력 등 여러 가지 복합적인 요인들 중 주름의 형성에 가장 큰 영향을 미치는 것은 콜라겐의 생성량과 콜라겐의 함량을 감소시키는 콜라겐 분해 효소인 콜라게네이즈의 발현량과 활성이다. 콜라게네이즈는 기질단백질 분해에 중요한 역할을 하는 금속단백분해효소(Matrix metalloproteinases, MMPs) 그룹에 속한다. 이러한 콜라게네이즈는 자외선, 성장인자, 염증성 사이토 카인, 포르볼 에스테르(phorbol ester)에 의해 발현이 촉진되어 제1,2,3,5형 교원질(collagen)을 분해하는 것으로 알려져 있으며, 특히 자외선에 의한 광노화에 주요한 역할을 담당하는 것으로 알려져 있다. As the skin ages, changes in the dermis appear remarkably, and changes in the dermis are caused by changes in substances having a large molecular weight in the extracellular matrix due to the decrease in the number of fibroblasts and their synthetic ability. The specific changes include separation of collagen bundles, reduction of viscopolysaccharide synthesis, reduction in the number and diameter of collagen and elastic fibers (elastin), decomposition of collagen and elastic fibers, and expansion of blood vessels. In general, among a number of complex factors, such as skin moisture content, collagen content, and immunity against the external environment, the biggest influence on the formation of wrinkles is cola, a collagen-degrading enzyme that reduces collagen production and collagen content. It is the expression level and activity of genease. Collagenase belongs to a group of metalloproteinases (MMPs) that play an important role in the degradation of matrix proteins. Collagenase is known to decompose type 1, 2, 3, and 5 collagen by promoting its expression by ultraviolet rays, growth factors, inflammatory cytokines, and phorbol esters. It is known to play a major role in photoaging caused by.
또한, 엘라스틴(elastin) 섬유는 콜라겐과 가교 결합을 형성하며 피부 탄력에 관여하고 있는 주름 생성에 중요한 피부 구성성분이다. 엘라스틴 섬유의 결핍과 응집, 엘라스틴 분해 효소인 엘라스타제(elastase)의 활성도의 현격한 증가는 피부 주름생성 요인 중의 하나로 밝혀지고 있다. 엘라스타제는 엘라스틴을 분해할 수 있는 유일한 효소로서 이에 대한 저해는 피부 주름 개선을 근본적으로 줄여줄 수 있다고 알려져 있다. In addition, elastin fibers form cross-links with collagen and are an important skin component for wrinkle formation, which is involved in skin elasticity. Deficiency and aggregation of elastin fibers, and a marked increase in the activity of elastase, an elastin-degrading enzyme, have been found to be one of the factors of skin wrinkle formation. Elastase is the only enzyme that can break down elastin, and its inhibition is known to fundamentally reduce the improvement of skin wrinkles.
대부분의 알려진 주름 개선 또는 미백 효과를 가진 피부 개선을 위한 물질들은 피부 적용시 자극, 발적 등의 안전성 문제로 사용량의 제한이 있거나, 효과가 미미하여 실질적으로 피부기능 개선 또는 상처 치유의 효과를 기대할 수 없었다. 따라서, 기존의 피부 개선용 화장료 조성물보다 생체에 안전하고 효과가 높은 새로운 피부 개선용 화장료 조성물의 개발이 절실히 요구되고 있다.Most of the known anti-wrinkle or whitening substances for skin improvement are limited in usage due to safety problems such as irritation and redness when applied to the skin, or the effect is insignificant, so the effect of substantially improving skin function or wound healing could not be expected. . Therefore, there is an urgent need to develop a new cosmetic composition for skin improvement that is safer to the living body and has a higher effect than the existing cosmetic composition for skin improvement.
본 출원이 해결하고자 하는 과제는 항산화, 피부 미백 또는 주름 개선 효과를 가지는 화장료 조성물 또는 식품 조성물에 유효성분으로 포함되는 대추씨 발효물을 제조하는 방법을 제공하는 것이다.The problem to be solved by the present application is to provide a method of preparing a fermented jujube seed contained as an active ingredient in a cosmetic composition or food composition having antioxidant, skin whitening or wrinkle improvement effects.
상술한 과제를 해결하기 위하여, 본 출원의 하나의 실시예는 대추씨 발효물의 제조방법을 제공한다.In order to solve the above-described problem, one embodiment of the present application provides a method of manufacturing a fermented jujube seed.
본 출원의 하나의 실시예에서, 상기 제조방법은, 대추에서 씨를 분리하여 분말화하는 단계; 대추씨 분말을 멸균한 후 유산균, 효모 또는 고초균을 접종하여 발효하여 대추씨 발효물을 수득하는 단계; 및 대추씨 발효물을 멸균한 후 불순물을 제거하는 단계;를 포함할 수 있다.In one embodiment of the present application, the manufacturing method comprises the steps of separating and pulverizing seeds from jujube; Sterilizing the jujube seed powder and then inoculating the lactic acid bacteria, yeast or Bacillus into fermentation to obtain a fermented jujube seed; And removing impurities after sterilizing the fermented jujube seed.
본 출원의 하나의 실시예에서, 상기 유산균, 효모 또는 고초균은, 락토바실러스 플란타륨(Lactobacillus plantarum), 바실러스 서브틸리스(Bacillus subtilis), 류코노스톡 메센테로이드(Leuconostoc mesenteroide) 또는 사카로미세스 세레비시아에(Saccharomyces cerevisiae)일 수 있다.In one embodiment of the present application, the lactic acid bacteria, yeast or Bacillus bacillus, Lactobacillus plantarum (Lactobacillus plantarum), Bacillus subtilis (Bacillus subtilis), Leuconostoc mecentroid (Leuconostoc mesenteroide ) or Saccharomyces cerevisiae .
본 출원의 하나의 실시예에서, 상기 분말화하는 단계는, 동결건조, 열풍건조 또는 자연건조하여 분쇄하거나, 냉장 또는 냉동 보관 후 분쇄하거나 파쇄하여 분말화할 수 있다. In one embodiment of the present application, the powdering may be pulverized by lyophilization, hot air drying, or natural drying, or may be pulverized or pulverized after refrigerated or frozen storage.
본 출원의 하나의 실시예에서, 상기 발효물을 수득하는 단계에서, 대추씨 분말과 배지를 1:4에서 1:20의 중량비로 혼합한 후 멸균할 수 있다.In one embodiment of the present application, in the step of obtaining the fermented product, the jujube seed powder and the medium may be mixed in a weight ratio of 1:4 to 1:20, and then sterilized.
본 출원의 하나의 실시예에서, 상기 발효물을 수득하는 단계에서, 발효는 100 rpm 내지 300 rpm, 20℃ 내지 45℃에서 1일 내지 10일 동안 배양함으로써 수행될 수 있다.In one embodiment of the present application, in the step of obtaining the fermented product, fermentation may be performed by culturing for 1 to 10 days at 100 rpm to 300 rpm, 20 to 45 °C.
본 출원의 하나의 실시예에서, 상기 불순물을 제거하는 단계는, 발효물을 0.3 ㎛ 내지 5 ㎛ 크기로 여과하거나, 원심분리하여 수행될 수 있다.In one embodiment of the present application, the step of removing the impurities may be performed by filtering the fermented product to a size of 0.3 µm to 5 µm or centrifuging.
본 출원의 하나의 실시예에서, 상기 멸균은 100℃ 내지 140℃에서 10분 내지 30분 동안 수행될 수 있다.In one embodiment of the present application, the sterilization may be performed at 100° C. to 140° C. for 10 to 30 minutes.
본 출원의 대추씨 발효물의 제조방법은 제조 효율과 생리활성이 증진되고, 버려지는 대추씨 부산물을 효율적으로 활용이 가능하여 제조 단가면에서 경쟁력 확보가 가능한 장점이 있다. The manufacturing method of fermented jujube seeds of the present application has the advantage of improving manufacturing efficiency and physiological activity, and enabling efficient use of discarded jujube seed by-products, thereby securing competitiveness in terms of manufacturing cost.
또한, 본 출원의 대추씨 발효물의 제조방법으로 제조한 대추씨 발효물은 멜라닌 생성을 효과적으로 억제하므로 피부 미백을 위한 기능성 화장품, 피부 색소 침착 질환을 예방 또는 개선시킬 수 있는 건강기능식품 또는 피부외용제 조성물로서 유용하게 사용할 수 있다.In addition, since the fermented jujube seed produced by the method for producing fermented jujube seeds of the present application effectively inhibits melanin production, functional cosmetics for skin whitening, health functional foods that can prevent or improve skin pigmentation disorders, or compositions for external use for skin It can be usefully used as
그리고, 본 출원의 대추씨 발효물의 제조방법으로 제조한 대추씨 발효물은 콜라겐 합성을 효과적으로 촉진하고, 엘라스타제 활성을 저하애하여 주름 개선을 위한 기능성 화장품, 피부 주름을 예방 또는 개선시킬 수 있는 건강기능식품 또는 피부외용제 조성물로서 유용하게 사용할 수 있다.In addition, the fermented jujube seed produced by the method for producing fermented jujube seeds of the present application effectively promotes collagen synthesis, reduces elastase activity, and thus functional cosmetics for wrinkle improvement, which can prevent or improve skin wrinkles. It can be usefully used as a health functional food or a composition for external skin.
또한, q본 출원의 대추씨 발효물의 제조방법으로 제조한 대추씨 발효물은 DPPH 라디칼과 ABTS 라디칼 소거 활성이 높고, 폴리페놀 함량이 높아 항산화 효과가 우수한 장점이 있다. In addition, q fermented jujube produced by the method of preparing fermented jujube seeds according to the present application has high DPPH radical and ABTS radical scavenging activity, and high polyphenol content, which has excellent antioxidant effects.
도 1은 본 출원의 일 실시예에 따라 제조한 대추씨 발효물의 제조공정을 나타낸 것이다.
도 1은 본 출원의 일 실시예에 따라 제조한 대추씨 발효물의 B16F0 세포배양액 멜라닌 저해 활성을 나타낸 것이다. 1 shows a manufacturing process of fermented jujube seeds prepared according to an embodiment of the present application.
1 shows the melanin inhibitory activity of B16F0 cell culture broth of fermented jujube seeds prepared according to an embodiment of the present application.
이하, 본 출원을 보다 상세히 설명한다.Hereinafter, the present application will be described in more detail.
본 출원의 개념에 따른 실시예는 다양한 변경을 가할 수 있고 여러가지 형태를 가질 수 있으므로 특정 실시예들은 본 명세서에 상세하게 설명하고자 한다. 그러나, 이는 본 출원의 개념에 따른 실시예들을 특정한 개시 형태에 한정하려는 것이 아니며, 본 출원의 사상 및 기술 범위에 포함되는 모든 변경, 균등물 내지 대체물을 포함하는 것으로 이해되어야 한다.Since the embodiments according to the concept of the present application can be modified in various ways and have various forms, specific embodiments will be described in detail in the present specification. However, this is not intended to limit the embodiments according to the concept of the present application to a specific form of disclosure, it should be understood to include all changes, equivalents, or substitutes included in the spirit and scope of the present application.
본 명세서에서 사용하는 용어는 단지 특정한 실시예를 설명하기 위해 사용된 것으로 본 출원을 한정하려는 의도가 아니다. 단수의 표현은 문맥상 명백하게 다르게 뜻하지 않는 한 복수의 표현을 포함한다.The terms used in the present specification are only used to describe specific embodiments and are not intended to limit the present application. Singular expressions include plural expressions unless the context clearly indicates otherwise.
명세서 전체에서, 어떤 부분이 어떤 구성요소를 "포함"한다고 할 때, 이는 특별히 반대되는 기재가 없는 한 다른 구성요소를 제외하는 것이 아니라 다른 구성요소를 더 포함할 수 있는 것을 의미한다.Throughout the specification, when a part "includes" a certain component, it means that other components may be further included rather than excluding other components unless specifically stated to the contrary.
다르게 정의되지 않는 한, 기술적이거나 과학적인 용어를 포함해서 여기서 사용되는 모든 용어들은 본 출원이 속하는 기술 분야에서 통상의 지식을 가진자에 의해 일반적으로 이해되는 것과 동일한 의미를 가지고 있다. 일반적으로 사용되는 사전에 정의되어 있는 것과 같은 용어들은 관련 기술의 문맥상 가지는 의미와 일치하는 의미를 갖는 것으로 해석되어야 하며, 본 명세서에서 명백하게 정의하지 않는 한 이상적이거나 과도하게 형식적인 의미로 해석되지 않는다.Unless otherwise defined, all terms including technical or scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this application belongs. Terms as defined in a commonly used dictionary should be interpreted as having a meaning consistent with the meaning in the context of the related technology, and should not be interpreted as an ideal or excessively formal meaning unless explicitly defined in the present specification. .
본 출원에 있어서, "대추"라는 용어는 대추의 껍질, 과육 및 씨를 포함하는 것으로 해석되며, 품종에 따른 제한은 없다. 본 출원에서는, 대추 전체가 갖는 각종 효능 및 활성보다는 대추씨가 갖는 효능 및 활성을 보유한 대추씨 발효물을 제조하고자 하는 바, 본 출원에 다른 대추씨 발효물의 제조방법에서는 먼저, 대추를 껍질, 과육, 및 씨로 분리함으로써, 대추씨 시료를 제조하는 단계를 수행하게 된다. In the present application, the term "jujube" is interpreted as including the skin, flesh and seeds of the jujube, and there is no limitation according to the variety. In the present application, it is intended to manufacture a fermented jujube seed that has the efficacy and activity of jujube seeds rather than the various effects and activities of the whole jujube. By separating into, and seeds, a step of preparing a sample of jujube seeds is performed.
상기 부위별 대추씨 시료는 바로 사용될 수도 있으나, 건조(열풍건조, 동결건조 등)하거나, 냉장 또는 냉동 보관된 것을 사용할 수도 있다. The jujube seed sample for each part may be used immediately, but dried (hot air drying, freeze drying, etc.), refrigerated or frozen storage may be used.
대추씨 시료에 대해서는 분말화 과정을 거치게 되는데, 이러한 분말화 과정에 의해 균일한 사이즈의 대추씨 분말 입자들이 얻어지게 된다. 특히, 분말화된 대추씨를 사용함으로써, 높은 표면적 및 이에 따른 추출 효과 극대화를 도모할 수 있게 된다. The jujube seed sample undergoes a pulverization process, and by this pulverization process, jujube seed powder particles having a uniform size are obtained. In particular, by using powdered jujube seeds, it is possible to maximize a high surface area and thus an extraction effect.
상기 대추씨 분말을 멸균한 후 균주를 접종하여 발효할 수 있다. After sterilizing the jujube seed powder, it can be fermented by inoculating the strain.
상기 대추씨 분말과 MRS 배지를 1:4에서 1:20의 중량비로 혼합한 후 멸균할 수 있다. 구체적으로 대추씨 분말과 MRS 배지를 1:4에서 1:10의 중량비로 혼합할 수 있다. 더욱 구체적으로 1:5의 중량비로 혼합할 수 있다.After mixing the jujube seed powder and the MRS medium in a weight ratio of 1:4 to 1:20, it can be sterilized. Specifically, jujube seed powder and MRS medium may be mixed in a weight ratio of 1:4 to 1:10. More specifically, it can be mixed in a weight ratio of 1:5.
상기 멸균 과정에 특별한 제한이 있는 것은 아니며, 예를 들어 열 살균, 초고온 순간 살균, 고온 장시간 살균, 감마선 조사 살균, 초고압 살균, 자외선 사균, 초음파 살균, 전자선 살균, 또는 화학 약품 살균 등을 이용하여 멸균 과정을 수행할 수 있으며, 그 외 미강 내 자체 미생물의 활성을 상실/살균 작용을 하는 것이라면 다른 방법이 적용될 수 있는데, 가장 구체적으로는 고온/고압 살균 (autoclaving) 처리를 100℃ 내지 140℃에서 10분 내지 30분 동안 수행하는 것일 수 있다. 상기, 고온/고압 살균 처리는 단단한 대추씨 세포벽 조직을 해리시킴으로써 유효 성분이 용이하게 용출되게 할 수 있으며, 균주에 의한 발효 효율 및 속도를 향상시킬 수 있고, 생리활성 물질의 함량을 증가시킬 수 있다는 효과가 있다.There are no particular restrictions on the sterilization process, for example, sterilization using heat sterilization, ultra-high temperature instant sterilization, high temperature long-term sterilization, gamma radiation sterilization, ultra-high pressure sterilization, ultraviolet ray killing, ultrasonic sterilization, electron beam sterilization, or chemical sterilization. The process can be performed, and other methods can be applied as long as it loses/sterilizes the activity of its own microorganisms in the rice bran, and most specifically, a high-temperature/high-pressure sterilization (autoclaving) treatment is performed at 100°C to 140°C. It may be performed for minutes to 30 minutes. The high-temperature/high-pressure sterilization treatment allows the active ingredient to be easily eluted by dissociating the hard jujube seed cell wall tissue, improves fermentation efficiency and speed by the strain, and increases the content of physiologically active substances. It works.
상기 균주는, 락토바실러스 플란타륨(Lactobacillus plantarum), 바실러스 서브틸리스(Bacillus subtilis), 류코노스톡 메센테로이드(Leuconostoc mesenteroide) 또는 사카로미세스 세레비시아에(Saccharomyces cerevisiae)일 수 있다.The strain may be Lactobacillus plantarum , Bacillus subtilis , Leuconostoc mesenteroide , or Saccharomyces cerevisiae .
상기 균주는 0.1중량% 내지 10 중량%, 0.5중량% 내지 1.0 중량%로 접종할 수 있다. The strain can be inoculated at 0.1% to 10% by weight and 0.5% to 1.0% by weight.
상기 발효는 20℃ 내지 45℃에서 1일 내지 10일 동안 100 rpm 내지 300 rpm으로 회전배양할 수 있다. 구체적으로 30℃ 내지 40℃에서 120 내지 180rpm의 조건으로 배양할 수 있다. The fermentation may be rotated at 100 rpm to 300 rpm for 1 to 10 days at 20°C to 45°C. Specifically, it can be cultured under the conditions of 120 to 180 rpm at 30 ℃ to 40 ℃.
발효 온도가 상기 범위 미만이면 피부미용에 유용한 물질의 추출 수율이 낮아지면서도 온도를 낮추기 위한 장비가 필요하므로 경제적이지 않으며, 교반 온도가 상기 범위를 초과하면 피부미용에 유용한 물질이 파괴되거나, 피부 미백, 주름 개선 등에 관여하지 않는 물질이 높은 함량으로 함께 추출될 수 있어 기능성이 저하된 발효물이 제조될 수 있어 바람직하지 않다. 예를 들어, 발효 온도가 20 내지 45 ℃의 온도범위 정도인 경우, 식물 세포 조직이 연화되어 미용 활성을 지니는 유효한 물질인 페놀류 등 성분의 용출이 용이해지므로 피부 미용 효능이 우수한 발효물을 얻을 수 있는 효과가 있다. 또한, 상기 배양이 1일 미만으로 수행되는 경우에는 시간이 불충분하여 대추씨 내 함유된 생리활성 성분이 완전히 용출되기 어려우며, 발효 시간이 10일을 초과하는 경우에는 대추씨에 함유된 생리활성 성분이 유의한 수준으로 증가하지 않으며, 오히려 과도한 배양으로 인하여 항산화, 피부 미백 활성이 저하된 발효물이 제조될 수 있다.If the fermentation temperature is less than the above range, it is not economical because equipment for lowering the temperature while the extraction yield of substances useful for skin beauty is lowered, and if the stirring temperature exceeds the above range, substances useful for skin beauty are destroyed or skin whitening , It is not preferable that a material that is not involved in wrinkle improvement, etc. can be extracted together in a high content, so that a fermented product with reduced functionality can be prepared. For example, when the fermentation temperature is in the range of 20 to 45 ℃, since the plant cell tissue is softened, the elution of ingredients such as phenols, which are effective substances having cosmetic activity, is facilitated, so that a fermented product having excellent skin beauty effects can be obtained. There is an effect. In addition, when the culture is performed for less than 1 day, the time is insufficient and it is difficult to completely elute the physiologically active ingredients contained in the jujube seeds. If the fermentation time exceeds 10 days, the physiologically active ingredients contained in the jujube seeds are It does not increase to a significant level, but rather, due to excessive cultivation, a fermented product with reduced antioxidant and skin whitening activity may be prepared.
발효 후 더 이상 발효가 진행되지 않도록 멸균처리할 수 있다. 그 이후 통상의 여과 방법 또는 장치를 이용하여 불순물을 제거할 수 있으며, 예를 들어 원심분리 방법을 이용하거나 마이크로 필터를 이용하여 여과하여 불순물이 제거된 발효물을 얻을 수 있다. 예를 들어, 사용가능한 마이크로 필터는 0.3 ㎛ 내지 5 ㎛ 크기의 기공을 갖는 필터를 사용할 수 있다. 구체적으로 3㎛ 크기의 기공을 갖는 필터를 사용하여 여과할 수 있다. 다른 예로, 1000 rpm 내지 2000 rpm에서 5분 내지 20분간 원심분리할 수 있다. 구체적으로 1500 rpm에서 10분간 원심분리하여 침전물은 버리고, 상층액만 수거하여 사용할 수 있다.After fermentation, it can be sterilized so that no further fermentation proceeds. Thereafter, impurities may be removed using a conventional filtration method or apparatus, and for example, a fermented product from which impurities have been removed may be obtained by filtration using a centrifugation method or a micro filter. For example, as the usable micro filter, a filter having pores of 0.3 μm to 5 μm may be used. Specifically, it can be filtered using a filter having a pore size of 3㎛. As another example, it may be centrifuged at 1000 rpm to 2000 rpm for 5 minutes to 20 minutes. Specifically, the precipitate was discarded by centrifugation at 1500 rpm for 10 minutes, and only the supernatant may be collected and used.
도 1을 참조하면, 일 실시예로서, 대추씨를 분쇄하는 단계(S1), 대추씨 분말와 배지를 혼합하는 단계(S2), 고압 멸균하는 단계 (S3), 균을 접종하는 단계 (S4), 진탕배양하는 단계 (S5), 고압 멸균하는 단계 (S6), 여과하는 단계 (S7)를 포함하여 대추씨 발효물의 제조방법을 나타내었다. Referring to Figure 1, as an embodiment, the step of pulverizing the jujube seeds (S1), the step of mixing the jujube seed powder and the medium (S2), the step of autoclaving (S3), the step of inoculating bacteria (S4), shaking It shows a method for producing a fermented jujube seed, including the step of culturing (S5), the step of autoclaving (S6), and the step of filtering (S7).
대추씨 발효물이 조성물의 총 중량을 기준으로 하여 0.0025 중량% 내지 30 중량%, 구체적으로 0.025 중량% 이상일 수 있고, 20 중량% 이하, 10중량% 이하, 5 중량 % 이하일 수 있다. 이 때 대추씨 발효물의 함량이 0.0025 중량% 미만일 경우 본 출원의 멜라닌 효과를 수득할 수 없으며, 30 중량% 를 초과할 경우 함량의 증가에 따라 효과가 비례적이지 않아 비효율적일 수 있으며 제형상의 안정성이 확보되지 않는 문제점이 있다. The fermented jujube seed may be 0.0025% by weight to 30% by weight, specifically 0.025% by weight or more, and may be 20% by weight or less, 10% by weight or less, or 5% by weight or less, based on the total weight of the composition. At this time, if the content of fermented jujube seeds is less than 0.0025% by weight, the melanin effect of the present application cannot be obtained, and if it exceeds 30% by weight, the effect may not be proportional to the increase in the content, and thus it may be inefficient. There is a problem that this is not secured.
대추씨를 에탄올과 같은 유기용매로 추출한 추출물은 화장료 조성물에 적합하지 않은 지용성 물질이 함께 추출되는 문제가 있다. 또한, 용매를 별도로 제거해야 하는 문제가 있다. 그러나, 본 출원의 대추씨 발효물은 지용성 물질이 추출되지 않아 유기용매로 추출할 때의 문제가 발생하지 않는 장점이 있다. The extract obtained by extracting jujube seeds with an organic solvent such as ethanol has a problem in that a fat-soluble substance that is not suitable for a cosmetic composition is extracted together. In addition, there is a problem in that the solvent must be removed separately. However, the fermented product of jujube seeds of the present application has the advantage that a problem when extracting with an organic solvent does not occur because a fat-soluble substance is not extracted.
본 출원의 하나의 실시예에 따라 제조된 대추씨 발효물은 화장료 조성물에 유효성분으로 포함될 수 있다. The fermented jujube seed prepared according to an exemplary embodiment of the present application may be included as an active ingredient in a cosmetic composition.
화장료 조성물에는 유효성분으로서의 대추씨 발효물 이외에 화장품 조성물에 통상적으로 첨가되는 성분, 예컨대 항산화제, 안정화제, 가용화제, 비타민, 안료 및 향료와 같은 통상적인 보조제, 및 담체를 추가로 첨가할 수 있다. In addition to the fermented jujube seed as an active ingredient, to the cosmetic composition, ingredients commonly added to the cosmetic composition, such as antioxidants, stabilizers, solubilizers, vitamins, pigments, and conventional auxiliary agents such as perfumes, and carriers may be additionally added. .
화장료 조성물은 당업계에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 예를 들어, 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제-함유 클린싱, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션 및 스프레이 등으로 제형화될 수 있으나, 이에 한정되는 것은 아니다. 보다 상세하게는, 영양 크림, 수렴 화장수, 유연 화장수, 로션, 에센스, 영양젤 또는 마사지 크림의 제형으로 제조될 수 있다. The cosmetic composition may be prepared in any formulation conventionally prepared in the art, for example, solutions, suspensions, emulsions, pastes, gels, creams, lotions, powders, soaps, surfactant-containing cleansing, oils, It may be formulated as a powder foundation, emulsion foundation, wax foundation, and spray, but is not limited thereto. In more detail, it may be prepared in the form of a nourishing cream, astringent lotion, a soft lotion, lotion, essence, a nourishing gel or a massage cream.
제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물성유, 식물성유, 왁스, 파라핀, 전분, 트라칸트검, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등 이 이용될 수 있다. When the formulation is a paste, cream or gel, animal oil, vegetable oil, wax, paraffin, starch, gum tracanth, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc, or zinc oxide may be used as a carrier component. .
제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로히드로카본, 프로판/부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다. When the formulation is a powder or spray, toss, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as a carrier component, and in particular, in the case of a spray, additionally chlorofluorohydrocarbon, propane/butane or Propellants such as dimethyl ether.
제형이 용액 또는 유탁액인 경우에는 담체 성분으로서 용매, 가용화제 또는 유탁화제가 이용되고, 예 컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌 글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르 가 있다. When the formulation is a solution or emulsion, a solvent, a solubilizing agent or an emulsifying agent may be used as a carrier component, such as water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1,3 -Butyl glycol oil, glycerol aliphatic ester, polyethylene glycol or fatty acid ester of sorbitan.
제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상의 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같 은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 검등이 이용될 수 있다. When the formulation is a suspension, liquid diluents such as water, ethanol or propylene glycol as carrier components, ethoxylated isostearyl alcohol, suspending agents such as polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, microcrystalline cellulose , Aluminum metahydroxide, bentonite, agar or tracant gum, etc. may be used.
제형이 계면-활성제 함유 클린징인 경우에는 담체 성분으로서 지방족 알코올 설페이트, 지방족 알코 올 에테르 설페이트, 설포숙신산 모노에스테르, 이세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성 유, 라놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 등이 이용될 수 있다.When the formulation is a surfactant containing cleansing, as a carrier component, aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, methyltaurate, sarcosinate, fatty acid amide ether sulfate , Alkylamidobetaine, fatty alcohol, fatty acid glyceride, fatty acid diethanolamide, vegetable oil, lanolin derivative or ethoxylated glycerol fatty acid ester, and the like may be used.
본 출원의 하나의 실시예에 따라 제조된 대추씨 발효물은 약학 조성물에 유효성분으로 포함될 수 있다. The fermented jujube seed prepared according to an embodiment of the present application may be included as an active ingredient in a pharmaceutical composition.
약학 조성물은 대추씨 발효물 이외에 약학적으로 허용되는 담체를 포함한다. 약학 조성물에 포함되는 약학적으로 허용되는 담체는 제제 시에 통상적으로 이용되는 것으로서, 락토스, 덱스트로스, 수크로스, 솔비톨, 만니톨, 전분, 아카시아 고무, 인산칼슘, 알기네이트, 젤라틴, 규산칼슘, 미세결정성 셀룰로스, 폴리비닐피롤리돈, 셀룰로스, 물, 시럽, 메틸 셀룰로스, 메틸히드록시벤조에이트, 프로필히드록시벤조에이트, 활석, 스테아르산 마그네슘 및 미네랄 오일 등을 포함하나, 이에 한정되는 것은 아니다. 본 출원의 약학적 조성물은 상기 성분들 이외에 윤활제, 습윤제, 감미제, 향미제, 유화제, 현탁제, 보존제 등을 추가로 포함할 수 있다. The pharmaceutical composition includes a pharmaceutically acceptable carrier in addition to the fermented jujube seed. Pharmaceutically acceptable carriers included in pharmaceutical compositions are commonly used in formulation, and include lactose, dextrose, sucrose, sorbitol, mannitol, starch, gum acacia, calcium phosphate, alginate, gelatin, calcium silicate, fine Crystalline cellulose, polyvinylpyrrolidone, cellulose, water, syrup, methyl cellulose, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate, mineral oil, and the like, but are not limited thereto. The pharmaceutical composition of the present application may further include a lubricant, a wetting agent, a sweetening agent, a flavoring agent, an emulsifying agent, a suspending agent, a preservative, and the like in addition to the above components.
약학 조성물은 경구 또는 비경구 투여할 수 있으며, 구체적으로는 비경구 투여, 보다 구체적으로는 도포에 의한 국부 투여(topical application) 방식으로 적용된다. The pharmaceutical composition may be administered orally or parenterally, specifically parenteral administration, and more specifically, applied by topical application by application.
약학 조성물의 적합한 투여량은 제제화 방법, 투여 방식, 환자의 연령, 체중, 성별, 병적 상태, 음식, 투여 시간, 투여 경로, 배설 속도 및 반응 감응성과 같은 요인들에 의해 다양하게 처방될 수 있다. 본 출원 의 약학적 조성물의 투여량은 성인 기준으로 0.001-100 ㎎/kg 범위 내이다. 또한 외용제인 경우에는 성인 기준으로 1.0 내지 3.0 ml의 양으로 1일 1회 내지 5회 도포하여 1개월 이상 계속 하는 것이 좋다. 다만, 상기 투여량은 본 출원의 범위를 한정하는 것이 아니다. A suitable dosage of the pharmaceutical composition can be prescribed in various ways depending on factors such as the method of formulation, mode of administration, age, weight, sex, pathological condition of the patient, food, time of administration, route of administration, rate of excretion and sensitivity to response. The dosage of the pharmaceutical composition of the present application is in the range of 0.001-100 mg/kg on an adult basis. In addition, in the case of an external preparation, it is recommended to apply once to 5 times a day in an amount of 1.0 to 3.0 ml based on an adult and continue for more than 1 month. However, the dosage does not limit the scope of the present application.
약학 조성물은 당분야의 통상의 지식을 가진 자가 용이하게 실시할 수 있는 방법에 따라, 약학적으 로 허용되는 담체 및/또는 부형제를 이용하여 제제화함으로써 단위 용량 형태로 제조되거나 또는 다용량 용기 내에 내입시켜 제조될 수 있다. 이 때 제형은 오일 또는 수성 매질중의 용액, 현탁액, 시럽제 또는 유화액 형태 이거나 엑시르제, 산제, 분말제, 과립제, 정제 또는 캅셀제 형태일 수도 있으며, 분산제 또는 안정화제를 추가 적으로 포함할 수 있다.The pharmaceutical composition is prepared in a unit dosage form by formulating using a pharmaceutically acceptable carrier and/or excipient according to a method that can be easily carried out by a person skilled in the art, or by being incorporated into a multi-dose container. Can be manufactured. In this case, the formulation may be in the form of a solution, suspension, syrup, or emulsion in an oil or aqueous medium, or may be in the form of an excir, powder, powder, granule, tablet or capsule, and may additionally include a dispersant or a stabilizer.
본 출원의 하나의 실시예에 따라 제조된 대추씨 발효물은 식품 조성물에 유효성분으로 포함될 수 있다. 식품은, 예를 들면, 건강보조식품, 기능성 식품, 식품첨가제 등으로 제공될 수 있다. The fermented jujube seed prepared according to an embodiment of the present application may be included as an active ingredient in a food composition. Food may be provided as, for example, health supplements, functional foods, food additives, and the like.
본 출원에서 사용된 용어 "식품"이란 영양소를 한 가지 또는 그 이상 함유하고 있는 천연물 또는 가공품을 의미하며, 구체적으로는 어느 정도의 가공 공정을 거쳐 직접 먹을 수 있는 상태가 된 것을 의미하며, 통상적인 의 미로서, 식품, 식품 첨가제, 기능성식품 및 음료를 모두 포함하는 의도이다. The term "food" as used in this application refers to a natural product or processed product containing one or more nutrients, and specifically refers to a state that can be eaten directly after a certain degree of processing By meaning, it is intended to include all foods, food additives, functional foods and beverages.
본 출원에서 사용된 용어 "기능성식품"이란 식품에 물리적, 생화학적, 생물공학적 수법 등을 이용하여 해당 식품의 기능을 특정 목적에 작용, 발현하도록 부가가치를 부여한 식품군이나 가공한 식품을 의미한다. The term "functional food" as used in this application refers to a food group or processed food in which added value is added to the food to act and express the function of the food for a specific purpose by using physical, biochemical, or biotechnological techniques.
상기 기능성식품에는 식품학적으로 허용 가능한 식품 보조 첨가제를 더욱 포함할 수 있으며, 기능성 식품의 제 조에 통상적으로 사용되는 적절한 담체, 부형제 및 희석제를 더욱 포함할 수 있다. The functional food may further include food additives that are acceptable food additives, and may further include suitable carriers, excipients, and diluents commonly used in the manufacture of functional foods.
식품으로는 예를 들어, 각종 식품류, 음료, 껌, 차, 비타민 복합제, 기능성 식품 등이 있다. 추가로, 본 출원에서 식품에는 특수영양식품(예, 조제유류, 영,유아식 등), 식육가공품, 어육제 품, 두부류, 묵류, 면류(예, 라면류, 국수류 등), 건강보조식품, 조미식품(예, 간장, 된장, 고추장, 혼합장 등), 소스류, 과자류(예, 스넥류), 유가공품(예, 발효유, 치즈 등), 기타 가공식품, 김치, 절임식품(각종 김치 류, 장아찌 등), 음료(예, 과실,채소류 음료, 두유류, 발효 음료류 등), 천연조미료(예, 라면 스프 등)을 포함 하나 이에 한정되지 않는다. 상기 식품, 음료 또는 식품첨가제는 통상의 제조방법으로 제조될 수 있다. Foods include, for example, various foods, beverages, gum, tea, vitamin complexes, and functional foods. In addition, foods in this application include special nutritional foods (eg, formula, infant food, etc.), processed meat products, fish meat products, tofu, muk, noodles (eg, ramen, noodles, etc.), health supplements, seasoning foods. (E.g. soy sauce, miso, red pepper paste, mixed sauce, etc.), sauces, confectionery (e.g. snacks), dairy products (e.g. fermented milk, cheese, etc.), other processed foods, kimchi, pickles (various kimchi, pickles, etc.), Beverages (eg, fruit, vegetable beverages, soy milk, fermented beverages, etc.), and natural seasonings (eg, ramen soup, etc.) are included, but are not limited thereto. The food, beverage or food additive may be prepared by a conventional manufacturing method.
식품으로는 기능성 음료로 제조되며, 기능성 음료란 음료에 물리적, 생화학적, 생물공학적 수법 등을 이용 하여 해당 음료의 기능을 특정 목적에 작용, 발현하도록 부가가치를 부여한 음료 군이나 음료 조성이 갖는 생체 방어리듬조절, 질병방지와 회복 등에 관한 체조절기능을 생체에 대하여 충분히 발현하도록 설계하여 가공한 음료를 의미하며, 특히 피부 탄력 향상, 콜라겐 합성 촉진을 위한 음료를 의미한다. As a food, it is manufactured as a functional beverage, and a functional beverage is a biological defense of a beverage group or beverage composition that gives added value to act and express the function of the beverage for a specific purpose by using physical, biochemical, and biotechnological techniques. It refers to a beverage designed and processed to sufficiently express the gymnastic function for rhythm control, disease prevention and recovery, etc. to the living body. In particular, it refers to a beverage that improves skin elasticity and promotes collagen synthesis.
식품 조성물은 여러 가지 영양제, 비타민, 광물(전해질), 합성 풍미제 및 천연 풍미제 등의 풍미제, 착 색제 및 중진제(치즈, 초콜릿 등), 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알코올, 탄산음료에 사용되는 탄산화제 등을 함유할 수 있다. 이러한 성분을 독립적으로 또는 조합하여 사용할 수 있다.Food compositions include various nutrients, vitamins, minerals (electrolytes), flavoring agents such as synthetic flavoring agents and natural flavoring agents, coloring agents and thickeners (cheese, chocolate, etc.), pectic acid and salts thereof, alginic acid and salts thereof, and organic acids. , A protective colloid thickener, a pH adjuster, a stabilizer, a preservative, a glycerin, an alcohol, a carbonation agent used in carbonated beverages, and the like. These components may be used independently or in combination.
이하, 제조예, 실시예, 실험예들을 통해서 본 출원을 더욱 구체적으로 설명하기로 하되, 하기 예는 본 출원의 이해를 돕기 위한 것일 뿐, 본 출원의 범위를 제한하는 것은 아니다.Hereinafter, the present application will be described in more detail through Preparation Examples, Examples, and Experimental Examples, but the following examples are intended to aid understanding of the present application and do not limit the scope of the present application.
<< 제조예Manufacturing example 1> 대추씨 시료 제조 1> Preparation of Jujube Seed Sample
한국에서 재배된 대추(Ziziphus jujuba var. spinosa)를 구입해 껍질, 과육, 및 씨로 분리하고 동결건조한 후 분쇄 과정을 거쳐 균일한 사이즈의 대추씨 분말 입자가 되도록 하였다. Jujube grown in Korea ( Ziziphus jujuba var. spinosa ) was purchased, separated into skin, pulp, and seeds, lyophilized, and pulverized to obtain uniform sized jujube seed powder particles.
<< 제조예Manufacturing example 2> 대추씨 2> Jujube seeds 발효물Fermented product 제조 Produce
균주는 유산균 2종 Lactobacillus plantarum (L. plantarum ), Leuconostoc mesenteroide (L. mesenteroide)와 효모 Saccharomyces cerevisiae (S. cerevisiae )와 고초균인 Bacillus subtilis (B. suntilis)로 생물자원센터 (Korean Collection for Type Cultures, KCTC)에서 분양받아 실험에 사용하였다. L. plantarum 의 생육배지로는 MRS Broth로 35℃에서 배양하였고, L . mesenteroide 의 생육배지로는 MRS Broth로 25℃에서 배양하였다. S. cerevisiae 생육배지로는 Potato Dextrose Broth 를 사용하여 25℃에서 배양하였으며, B. suntilis 생육배지로는 Trytic Soy Broth 를 사용하여 35℃에서 배양하였다.Two strains of lactobacillus Lactobacillus plantarum (L. plantarum ) , Leuconostoc mesenteroide (L. mesenteroide) and yeast S accharomyces cerevisiae (S. cerevisiae ) and Bacillus subtilis (B. suntilis) , which are Bacillus subtilis, were sold in the Korean Collection for Type Cultures (KCTC) and used for experiments. L. plantarum In the growth medium it was incubated at 35 ℃ in MRS Broth, L. The growth medium of mesenteroide was cultured at 25℃ with MRS Broth. S. cerevisiae growth medium was cultured at 25℃ using Potato Dextrose Broth, and B. suntilis As a growth medium, Trytic Soy Broth was used and incubated at 35°C.
대추씨 분말과 배지를 1:4 내지 1:20의 비율로 혼합한 후 121℃에서 15분 동안 고압 멸균한 후 미리 배양된 균들을 0.85% 접종하였다. 35℃, 150rpm에서 5일간 진탕배양한 후 더 이상 발효되지 않도록 121℃에서 20분 동안 고압멸균하였다. 배양 완료 후 1,500rpm에서 10분간 원심분리하여 침전물은 버리고 상층액만 수거하여 대추씨 발효물을 제조하였다. The jujube seed powder and the medium were mixed in a ratio of 1:4 to 1:20, autoclaved at 121°C for 15 minutes, and then 0.85% of previously cultured bacteria were inoculated. After shaking culture at 35°C and 150rpm for 5 days, it was autoclaved at 121°C for 20 minutes to prevent further fermentation. After completion of the culture, centrifugation was performed at 1,500 rpm for 10 minutes to discard the precipitate and collect only the supernatant to prepare a fermented jujube seed.
<< 실시예Example 1 내지 1 to 실시예Example 5> 5>
대추씨 분말과 배지의 함량비는 1:10로 하여 Lactobacillus plantarum(실시예 1), Leuconostoc mesenteroide(실시예 2), Saccharomyces cerevisiae(실시예 3), Bacillus subtilis(실시예 4)의 대추씨 발효액을 상기 제조예 2에 따라 제조하였다. 또한, 대추씨분말 200 mg과 배지 1,000 mg을 사용한 1:5의 함량비로 하여 Lactobacillus plantarum(실시예 5)의 대추씨 발효액을 제조예 2에 따라 제조하였다. Lactobacillus plantarum (Example 1), Leuconostoc mesenteroide (Example 2), S accharomyces cerevisiae (Example 3) and Bacillus subtilis (Example 4) fermented jujube seeds were prepared according to Preparation Example 2. In addition, Lactobacillus was prepared in a ratio of 1:5 using 200 mg of jujube seed powder and 1,000 mg of medium. A fermented jujube seed broth of plantarum (Example 5) was prepared according to Preparation Example 2.
<< 비교예Comparative example 1> 1>
대추씨 분말을 70% 에탄올로 추출하여 대추씨 추출물을 제조하였다. Jujube seed powder was extracted with 70% ethanol to prepare a jujube seed extract.
<< 실험예Experimental example 1> 대추씨 1> Jujube seeds 발효물의Fermented DPPHDPPH 라디칼 Radical 소거능Erasing ability 측정 Measure
실시예 1 내지 실시예 5의 대추씨 발효물로 DPPH assay를 Yoshida et al. (1989)이 사용한 방법에 따라 측정하였다. 96well plate에 control에는 탈이온수 50㎕, 시험군에는 탈이온수로 희석한 시료를 50ul 씩 triple로 넣는다. 에탄올을 모든 웰에 25㎕씩 넣고 75㎕의 DPPH(0.5mM 1,1-diphenyl-2- picrylhydrazyl(DPPH)/ethanol) 용액을 가하여 혼합한다. 25℃의 실온에서 30분 동안 반응시킨 후 517nm에서 흡광도를 측정하였다. 용매 대조군으로 하여 대조군에 대한 라디칼 소거능을 백분율로 나타내었다.DPPH assay with the fermented jujube seeds of Examples 1 to 5 was performed by Yoshida et al. It was measured according to the method used by (1989). In a 96 well plate, add 50 µl of deionized water to the control and 50 µl of the sample diluted with deionized water in the test group as a triple. 25 µl of ethanol was added to all wells, and 75µl of DPPH (0.5mM 1,1-diphenyl-2-picrylhydrazyl(DPPH)/ethanol) solution was added and mixed. After reacting at room temperature at 25° C. for 30 minutes, absorbance was measured at 517 nm. As a solvent control, the radical scavenging ability relative to the control was expressed as a percentage.
대추씨 발효액의 Radical 소거능은 농도 의존적인 활성 증가를 확인하여 하기 표 1에 나타내었다. 실시예 5의 대추씨 발효액의 DPPH 라디칼 소거활성은 50 % 의 농도에서 69.1 %의 활성을 보여주었고, IC50 은 DPPH 라디칼 소거활성은 18.7 %이었다. Radical scavenging ability of the fermented jujube seed was shown in Table 1 below by confirming the concentration-dependent increase in activity. The DPPH radical scavenging activity of the fermented jujube seed of Example 5 was 69.1% at a concentration of 50%, and the IC 50 was 18.7% DPPH radical scavenging activity.
<< 실험예Experimental example 2> 대추씨 2> Jujube seeds 발효물의Fermented ABTSABTS 라디칼 Radical 소거능Erasing ability 측정 Measure
실시예 1 내지 실시예 5와 비교예 1의 대추씨 발효물로 ABTS assay 를 Re et al.(1999)의 방법을 변형하여 측정하였다. 즉, 7 mM ABTS 5 mL와 140 mM potassium persulfate 88 ㎕를 섞은 후 상온에서 16시간 빛을 차단하여 ABTS 양이온을 형성시킨다. 이후 이 용액을 414 nm에서 흡광도 값이 1.5가 되도록 PBS로 희석하였다. 조제된 희석용액 190 ㎕와 시료 10 ㎕를 혼합한 후 상온에서 6분간 반응시킨 후 734 nm에서 흡광도를 측정하였다. 용매 대조군으로 하여 대조군에 대한 라디칼 소거능을 백분율로 나타내었다.The ABTS assay was measured by modifying the method of Re et al. (1999) with the fermented jujube seeds of Examples 1 to 5 and Comparative Example 1. That is, after mixing 5 mL of 7 mM ABTS and 88 μL of 140 mM potassium persulfate, the ABTS cation is formed by blocking light for 16 hours at room temperature. Thereafter, this solution was diluted with PBS so that the absorbance value was 1.5 at 414 nm. 190 µl of the prepared diluted solution and 10 µl of the sample were mixed, reacted at room temperature for 6 minutes, and absorbance was measured at 734 nm. As a solvent control, the radical scavenging ability relative to the control was expressed as a percentage.
대추씨 발효액의 Radical 소거능은 농도 의존적인 활성 증가를 확인하여 하기 표 2에 나타내었다. 대추씨 발효액의 ABTS 라디칼 소거활성은 1% 의 농도에서 77.6 %의 활성을 보여주었고, IC50 은 ABTS 라디칼 소거활성은 0.56 %이었다. 대추씨의 에탄올 추출물인 비교예 1의 1%와 실시예 1의 1%를 비교할 때 ABTS 소거 활성 효과에 현저한 차이가 있는 것을 확인할 수 있다.Radical scavenging activity of the fermented jujube seed was shown in Table 2 below by confirming the concentration-dependent increase in activity. The ABTS radical scavenging activity of jujube seed fermentation broth was 77.6% at the concentration of 1%, and the ABTS radical scavenging activity of IC 50 was 0.56%. When comparing 1% of Comparative Example 1, which is an ethanol extract of jujube seeds, and 1% of Example 1, it can be seen that there is a remarkable difference in the ABTS scavenging activity effect.
실시예 1 내서 실시예 5와 비교하였을 때 실시예 5가 가장 높은 활성을 나타내어 이하 활성은 Lactobacillus plantarum(실시예 5)로 하였다.As compared with Example 5 in Example 1, Example 5 showed the highest activity, and the following activity was Lactobacillus plantarum (Example 5).
<< 실험예Experimental example 3> 대추씨 3> Jujube seeds 발효물의 MushroomMushroom of fermented material TyrosinaseTyrosinase 저해 활성 측정 Inhibitory activity measurement
실시예 5의 대추씨 발효물로 기능성 화장품 평가 가이드라인의 실험법을 참고하여 Mushroom Tyrosinase 저해 활성 실험을 수행하였다. 타이로시나제는 인체 내 멜라닌 생합성 경로에서 가장 중요한 초기속도결정단계에 관여하는 효소로서, 이 효소의 활성 저해는 멜라닌 생성을 저해하는 결과를 나타낸다. 이 시험은 시험관 내에서 시험시료, 정제된 타이로시나제 및 기질인 타이로신을 반응시켜 타이로시나제 활성 저해에 대한 시험시료의 효과를 평가하는 방법이다. 먼저 시료를 증류수에 녹이고, 대추씨 발효액을 5, 10, 25, 50 % 농도로 희석하여 Mushroom Tyrosinase 저해 활성을 측정하였다.Mushroom Tyrosinase inhibitory activity experiment was performed with the fermented jujube seed of Example 5 with reference to the experimental method of the functional cosmetics evaluation guideline. Tyrosinase is an enzyme that is involved in the most important early rate-determining step in the melanin biosynthesis pathway in the human body, and inhibition of the activity of this enzyme shows the result of inhibiting melanin production. This test is a method of evaluating the effect of a test sample on inhibition of tyrosinase activity by reacting a test sample, purified tyrosinase, and a substrate tyrosine in vitro. First, the sample was dissolved in distilled water, and the jujube seed fermentation broth was diluted to 5, 10, 25, 50% concentration to measure Mushroom Tyrosinase inhibitory activity.
시험관에 인산염완충액(pH 6.5) 220 ㎕, 시료 20 ㎕, 머쉬룸 타이로시나제액(1500 ~ 2000 U/mL) 20 ㎕를 순서대로 넣었다. 이 액에 1.5mM 타이로신액 40㎕를 넣고 37℃에서 10~15분 동안 반응시킨 다음 490nm에서 흡광도를 측정하였다. 활성 저해율이 50% 일 때의 시료 농도(IC50)를 산출하였다. 시료액 대신 시료를 녹인 용매를 공시료액으로 하여 보정하였고 양성대조군으로는 알부틴을 사용하여 결과를 비교하여 표 3에 나타내었다.In the test tube, 220 µl of a phosphate buffer (pH 6.5), 20 µl of a sample, and 20 µl of a mushroom tyrosinase solution (1500-2000 U/mL) were sequentially added. To this solution, 40 µl of 1.5 mM tyrosine solution was added and reacted at 37° C. for 10 to 15 minutes, and the absorbance was measured at 490 nm. The sample concentration (IC 50 ) when the activity inhibition rate was 50% was calculated. Instead of the sample solution, the solvent in which the sample was dissolved was used as the sample solution, and the results were compared using arbutin as a positive control, and the results are shown in Table 3.
대추씨 발효액은 농도가 증가함에 따라 저해 활성이 증가하는 것을 알 수 있었다. It was found that the inhibitory activity of the jujube seed fermentation broth increased as the concentration increased.
<< 실험예Experimental example 4> 대추씨 4> Jujube seeds 발효물의 세포독성Cytotoxicity of fermented products 측정 Measure
실시예 5의 대추씨 발효물로 기능성 화장품 평가 가이드라인의 실험법을 참고하여 멜라닌 저해 활성 실험을 수행하였다. 이 시험은 미백성분에 대한 세포의 멜라닌 생성 저해 효과를 평가하는 방법으로 세포를 배양하여 세포 내 멜라닌의 양 또는 세포 내외의 총 멜라닌 양을 정량화하여 공시료액과 비교하였다. With the fermented jujube seed of Example 5, a melanin inhibitory activity experiment was performed with reference to the experimental method of the functional cosmetics evaluation guideline. This test is a method of evaluating the inhibitory effect of cell melanogenesis on the whitening component. Cells were cultured to quantify the amount of melanin in the cell or the total amount of melanin inside and outside the cell, and compared with the blank sample.
시료의 멜라닌 생성 저해능을 보기 위하여 멜라닌 세포인 B16F0를 사용하였다. 세포 배양용 플라스크에 B16F0 세포주를 DMEM에 10% FBS를 첨가한 배지로 37℃, 습도 95%, CO2 5% 조절된 CO2 배양기에서 배양하였다.B16F0, which is a melanocyte, was used to examine the melanin production inhibitory ability of the sample. The B16F0 cell line was cultured in a cell culture flask in a CO 2 incubator at 37° C., 95% humidity, and 5% CO 2 in a medium in which 10% FBS was added to DMEM.
B16F0 세포주를 1x10⁴/well의 농도로 96well plate에 분주하고 24시간 동안 37℃, 습도 95%, CO2 5%로 조절된 CO2 배양기에서 배양하였다. 새로운 배지에 시료를 농도별로 제조하여 세포주에 처리한 후 24시간 동안 배양하였다. 세포주의 생존률을 측정하기 위해 MTS 시약을 이용하여 microplate reader(Molecular Devices, VersaMax ELISA Microplate Reader, USA)로 490 nm에서 흡광도를 측정하였다. 세포의 생존율은 시료를 처리하지 않은 대조군에 대비한 시료 처리군의 흡광도로 표시하였다. 멜라닌 생성을 유도하기 위해 alpha-MSH을 사용하였다. Control(-)에는 무처리군으로 하였고, Control(+) 군에는 alpha-MSH 만을 2 μM 농도로 처리하였다. 대추씨 발효액에는 같은 농도의 alpha-MSH와 함께 대추씨 발효액을 희석하여 처리하였다. 72시간동안 배양한 다음 독성을 측정하였다.The B16F0 cell line was dispensed into a 96-well plate at a concentration of 1×10⁴/well, and cultured in a CO 2 incubator controlled at 37° C., 95% humidity, and 5% CO 2 for 24 hours. Samples were prepared by concentration in a new medium, treated with cell lines, and cultured for 24 hours. To measure the viability of the cell line, absorbance was measured at 490 nm with a microplate reader (Molecular Devices, VersaMax ELISA Microplate Reader, USA) using MTS reagent. The viability of the cells was expressed as the absorbance of the sample-treated group compared to the control group not treated with the sample. Alpha-MSH was used to induce melanin production. Control (-) was treated as an untreated group, and only alpha-MSH was treated at a concentration of 2 μM in the Control (+) group. The jujube seed fermentation broth was treated by diluting the jujube seed fermentation broth with the same concentration of alpha-MSH. After incubation for 72 hours, toxicity was measured.
최고 농도인 0.5 % 농도에서 독성이 나타나 세포 외·내 멜라닌 함량은 0.0025 % ~ 0.25% 농도 범위에서 측정하여 하기 표 4에 나타내었다.Toxicity was observed at the highest concentration of 0.5%, and the extracellular/intracellular melanin content was measured in a concentration range of 0.0025% to 0.25%, and is shown in Table 4 below.
<< 실험예Experimental example 4> 대추씨 4> Jujube seeds 발효물의Fermented 세포외Extracellular 멜라닌 함량 측정 Melanin content measurement
B16F0 세포주를 6-well plate에 1±105개cell/well로 분주하고 24시간 동안 37℃, 습도 95%, CO2 5%로 조절된 CO2 배양기에서 배양하였다. phenol red가 포함되지 않은 DMEM배지에 시료를 농도별로 제조하여 세포주에 처리한 후 24시간 동안 배양하였다. 배지에 a-MSH을 처리하여 멜라닌 생성 과정을 촉진하였다. 세포의 배지는 다른 용기에 옮기고, 남은 세포는 PBS로 세척한 후 회수하여 cell lysis buffer를 이용하여 단백질 양을 구한다. 배지는 490 nm에서 흡광도를 측정하고, 합성 멜라닌을 이용한 검량선으로부터 멜라닌의 양을 구했다. 멜라닌 양은 세포 일정 수 당 멜라닌 양 또는 일정 단백질 당 멜라닌 양으로 환산하고, 시료를 녹인 용매를 처리한 대조구의 결과와 비교하였다. Control(-)에는 무처리군으로 하였고, Control(+) 군에는 alpha-MSH 만을 2 μM 농도로 처리하여 실시예 5의 대추씨 발효액의 B16F0 세포 외 멜라닌 함량 측정 결과를 하기 표 5와 도 1에 나타내었다. The B16F0 cell line was dispensed into a 6-well plate at 1±10 5 cells/well and cultured in a CO 2 incubator controlled at 37° C., 95% humidity, and 5% CO 2 for 24 hours. Samples were prepared by concentration in DMEM medium containing no phenol red, treated with cell lines, and cultured for 24 hours. The medium was treated with a-MSH to promote the melanin production process. Cell medium is transferred to another container, and the remaining cells are washed with PBS and recovered, and the amount of protein is determined using cell lysis buffer. As for the medium, absorbance was measured at 490 nm, and the amount of melanin was calculated from a calibration curve using synthetic melanin. The amount of melanin was converted into the amount of melanin per certain number of cells or the amount of melanin per certain protein, and compared with the results of a control treated with a solvent in which the sample was dissolved. Control (-) was a non-treatment group, and only alpha-MSH was treated at a concentration of 2 μM in the Control (+) group, and the results of measuring the B16F0 extracellular melanin content of the fermentation broth of jujube seeds of Example 5 are shown in Table 5 below and FIG. Indicated.
대추씨 발효액 0.1 % 농도 일 때, 37.0%의 저해 활성을 보여주었고, 0.25% 농도 일 때는 53.8 %의 높은 저해활성을 보여주었다. 양성 대조군인 알부틴은 0.01% 농도에서 35.4%, 0.1% 농도에서 62.7%의 높은 활성을 보여주었다. 대추씨 발효액 0.1%와 알부틴 0.01%에서 유사한 멜라닌 생성 저해능을 보여주어, 1/5 정도의 활성을 확인할 수 있었다. When the concentration of fermented jujube was 0.1%, the inhibitory activity was 37.0%, and at the concentration of 0.25%, the inhibitory activity was 53.8%. Arbutin, a positive control, showed high activity of 35.4% at a concentration of 0.01% and 62.7% at a concentration of 0.1%. Jujube seed fermentation broth 0.1% and arbutin 0.01% showed similar melanin production inhibitory ability, confirming the activity of about 1/5.
세포외 멜라닌 함량으로 보았을 때. 알부틴의 1kg 당 단가는 16만원선이며, 대추씨 발효액의 가격은 이의 1/10 정도로 경제적인 측면에서 약 2배의 비용절감 효과를 확인할 수 있었다. In terms of extracellular melanin content. The unit price per 1 kg of arbutin is around 160,000 won, and the price of fermented jujube seeds is about 1/10 of this, and it was confirmed that the cost reduction effect was about 2 times in terms of economy.
저해활성 (%)Extracellular melanin
Inhibitory activity (%)
(%)IC 50
(%)
(%)IC 15
(%)
<< 실험예Experimental example 5> 대추씨 5> Jujube seeds 발효물의Fermented TyrosinaseTyrosinase 저해 활성 측정 Inhibitory activity measurement
B16F10 세포를 6 well plate에 각 1±105 cells/1.5ml/well의 농도로 분주한 후, 부착 및 안정화를 위해 24 시간 동안 incubation한 다음 4μM Tyrosine과 대추씨 발효액 0.0025 ~ 0.25 %까지의 농도로 처리한 후 37℃, 5% CO2 incubator에서 48 시간을 추가로 배양하였다. 배양한 후, 세포를 1% Triton X-100을 함유한 10 mM PBS 100 ㎕에 현탁시킨 후 세포를 vortexing한 후 1,000 rpm에서 5 분간 원심분리하여 상층액을 활성 측정 효소액으로 이용하였다. 티로시네이즈의 활성을 측정하기 위하여 96 well plate에 기질인 L-DOPA (2 ㎎/㎖) 100 ㎕를 넣고, 효소액 40 ㎕를 첨가한 후 37℃, 5% CO2 incubator에서 1 시간 동안 반응한 후 Microplate Reader 를 사용하여 405 ㎚에서 측정하였다. 실시예 5와 비교예1에 대한 티로시네이즈의 활성 저해율은 대조군의 흡광도에 대한 백분율로 계산하여 하기 표 6에 나타내었다.B16F10 cells were dispensed into a 6 well plate at a concentration of 1±10 5 cells/1.5ml/well, incubated for 24 hours for adhesion and stabilization, and then 4μM Tyrosine and jujube seed fermentation broth at a concentration of 0.0025 ~ 0.25%. After treatment, the cells were further cultured for 48 hours in a 5% CO2 incubator at 37°C. After incubation, the cells were suspended in 100 µl of 10 mM PBS containing 1% Triton X-100, vortexed, and centrifuged at 1,000 rpm for 5 minutes, and the supernatant was used as an enzyme solution for measuring activity. To measure the activity of tyrosinase, 100 µl of L-DOPA (2 mg/ml) as a substrate was added to a 96 well plate, 40 µl of enzyme solution was added, and then reacted in a 5% CO2 incubator at 37°C for 1 hour. Measurements were made at 405 nm using a Microplate Reader. The inhibition rate of tyrosinase activity for Example 5 and Comparative Example 1 was calculated as a percentage of the absorbance of the control group and is shown in Table 6 below.
대추씨 발효액 0.1 % 농도 일 때, 95.2 %의 저해 활성을 보여주었고, 0.25% 농도 일 때는 98.7 %의 높은 저해활성을 보여주었다. 양성 대조군인 알부틴은 0.01% 농도에서 99.5 %, 0.1% 농도에서 99.8 %의 높은 활성을 보여주었다. 대추씨 발효액 0.1%와 알부틴 0.01%에서 유사한 Tyrosinase 저해능을 확인할 수 있었고 IC50 은 0.05%로 확인하였다. 이는 대추씨 발효액의 약 0.1% 만 사용하여도 미백 효과가 매우 높은 것을 확인할 수 있다. 대추씨의 에탄올 추출물인 비교예 1은 티로시나제 저해 활성이 없는 것을 확인할 수 있다.When the jujube seed fermentation broth was at 0.1% concentration, it showed 95.2% inhibitory activity, and at 0.25% concentration, it showed a high inhibitory activity of 98.7%. Arbutin, a positive control, showed high activity of 99.5% at the concentration of 0.01% and 99.8% at the concentration of 0.1%. Similar Tyrosinase inhibitory activity was confirmed in 0.1% of jujube seed fermentation broth and 0.01% of arbutin, and IC 50 was confirmed to be 0.05%. It can be seen that the whitening effect is very high even when only about 0.1% of the fermented jujube seed is used. It can be seen that Comparative Example 1, which is an ethanol extract of jujube seeds, has no tyrosinase inhibitory activity.
(%)IC 50
(%)
(%)IC 20
(%)
<< 실험예Experimental example 6> 대추씨 6> Jujube seeds 발효물의Fermented CollagenaseCollagenase 저해 활성 측정 Inhibitory activity measurement
콜라게나제 저해활성은 Invitrogen사의 EnzChek®Gelatinase/Collagenase Assay Kit (250-2000 Assays) 시약을 구입하여 사용하였다. 먼저 1 mg DQ collagen vial에 1.0 ml의 DDW를 가해 DQ collagen stock solution (1 mg/ml)을 제조했다. 10 x reaction buffer 2 ml에 DDW 18 ml를 가해 reaction buffer를 희석했다. 다음으로 collagenase 효소 시약을 제조하였다. Working solution으로 최종 농도가 0.2 U/ml이 되도록 reaction buffer로 희석했다. 시료를 96well plate에 50 ㎕씩 triple로 준비하였다. DQ collagen 20 ㎕와 sample blank에는 reaction buffer 30 ㎕, sample에는 working solution 30 ㎕를 시료에 가하고, 빛을 차단한 상태로 실온에서 1~2 시간 동안 방치한 후 형광 강도 excitation wavelength 485 nm 및 emission wavelength 535 nm에서 ELISA plate reader (VICTOR X3™, PerkinElmer, US)로 형광강도를 측정하여 하기 수학식 3에 따라 계산하여 표 7에 나타내었다.For collagenase inhibitory activity, Invitrogen's EnzChek® Gelatinase/Collagenase Assay Kit (250-2000 Assays) reagent was purchased and used. First, a DQ collagen stock solution (1 mg/ml) was prepared by adding 1.0 ml of DDW to a 1 mg DQ collagen vial. The reaction buffer was diluted by adding 18 ml of DDW to 2 ml of 10 x reaction buffer. Next, a collagenase enzyme reagent was prepared. It was diluted with a reaction buffer to a final concentration of 0.2 U/ml with a working solution. Samples were prepared in a 96 well plate in a triple manner by 50 µl. Add 20 µl of DQ collagen and 30 µl of reaction buffer to the sample blank, 30 µl of working solution to the sample, and leave it for 1 to 2 hours at room temperature in a state of blocking light. The fluorescence intensity was measured with an ELISA plate reader (VICTOR X3™, PerkinElmer, US) at nm, calculated according to Equation 3 below, and shown in Table 7.
실시예 5와 비교예 1의 대추씨 발효액의 Collagenase 저해 활성 측정 결과 0.5 % 농도에서 46.2 %의 저해활성을 확인할 수 있었고 농도가 증가할수록 Collagenase 저해 활성이 증가하는 것을 알 수 있었다. 주름개선 기능성 성분인 아데노신과 비교하였을 때, 50 ug/ml 농도와 대추씨 발효액 0.1 % 농도가 비슷한 저해 활성을 가지는 것을 알 수 있다. IC50은 0.5%로 확인하였고, 대추씨 발효액을 약 0.5%만 사용하여도 주름 개선 효과가 매우 좋음을 확인할 수 있다. 대추씨의 에탄올 추출물인 비교예 1은 100%의 활성이 60.09±0.51로서, 실시예 1의 1%의 활성보다 현저히 낮은 것을 확인할 수 있다.As a result of measuring the collagenase inhibitory activity of the fermented jujube seeds of Example 5 and Comparative Example 1, the inhibitory activity of 46.2% was confirmed at 0.5% concentration, and it was found that the collagenase inhibitory activity increased as the concentration increased. When compared with adenosine, which is a functional ingredient for improving wrinkles, it can be seen that the concentration of 50 ug/ml and the concentration of 0.1% jujube seed fermentation broth have similar inhibitory activity. The IC 50 was confirmed to be 0.5%, and it can be confirmed that the wrinkle improvement effect is very good even when only about 0.5% of the fermented jujube seed is used. In Comparative Example 1, which is an ethanol extract of jujube seeds, it can be seen that the activity of 100% is 60.09±0.51, which is significantly lower than that of 1% of Example 1.
(ug/ml)Adenosine
(ug/ml)
<< 실험예Experimental example 7> 대추씨 7> Jujube seeds 발효물의Fermented ElastaseElastase 저해 활성 측정 Inhibitory activity measurement
엘라스타제 저해활성은 Invitrogen사의 EnzChek®Elastase Assay Kit (600 Assays) 시약을 구입하여 사용하였다. 먼저 1 mg DQ Elastin vial에 1.0 ml의 DDW를 가해 DQ elastin stock solution (1 mg/ml)을 제조했다. 10 x reaction buffer 2 ml에 DDW 18 ml를 가해 reaction buffer를 희석했다. 다음으로 elastase 효소 시약을 제조하였다. Working solution으로 최종 농도가 0.2 U/ml이 되도록 reaction buffer로 희석했다. 시료를 96well plate에 50 ㎕씩 triple로 준비한다. DQ elastin 50 ㎕와 sample blank에는 reaction buffer 50 ㎕, sample에는 working solution 50 ㎕를 시료에 가하고, 빛을 차단한 상태로 실온에서 1시간 동안 방치한 후 형광 강도 excitation wavelength 505 nm 및 emission wavelength 515 nm에서 ELISA plate reader (VICTOR X3™, PerkinElmer, US)로 형광강도를 측정하여 하기 수학식 4에 따라 계산하여 그 결과를 하기 표 8에 나타내었다. For elastase inhibitory activity, Invitrogen's EnzChek® Elastase Assay Kit (600 Assays) reagent was purchased and used. First, DQ elastin stock solution (1 mg/ml) was prepared by adding 1.0 ml of DDW to a 1 mg DQ Elastin vial. The reaction buffer was diluted by adding 18 ml of DDW to 2 ml of 10 x reaction buffer. Next, an elastase enzyme reagent was prepared. It was diluted with a reaction buffer to a final concentration of 0.2 U/ml with a working solution. Prepare a sample in a 96 well plate in a triple manner by 50 µl each. Add 50 µl of DQ elastin and 50 µl of reaction buffer to the sample blank, 50 µl of working solution to the sample, and leave it for 1 hour at room temperature in a state of blocking light. The fluorescence intensity was measured with an ELISA plate reader (VICTOR X3™, PerkinElmer, US) and calculated according to Equation 4 below, and the results are shown in Table 8 below.
실시예 5와 비교예1의 대추씨 발효액의 Elastase 저해 활성 측정 결과 비교 대조군인 Elastase inhibitor의 0.00025 % 농도와 대추씨 발효액 30 % 농도가 비슷한 Elastase 저해 활성을 가지는 것으로 보인다. 또한 대추씨 발효액은 농도가 증가함에 따라 Elastase 저해 활성이 증가하는 것을 알 수 있고, IC50은 16.9 %로 확인하였다. 이는 대추씨 발효액을 약 16.9 %만 사용하여도 주름 개선에 매우 효과가 좋음을 확인할 수 있다. 대추씨의 에탄올 추출물인 비교예 1은 엘라스타제 저해 활성이 없는 것을 확인할 수 있다.As a result of measuring the Elastase inhibitory activity of the fermented jujube seeds of Example 5 and Comparative Example 1, the concentration of 0.00025% of the Elastase inhibitor, which is a comparative control, and 30% of the fermented jujube seed, appear to have similar Elastase inhibitory activity. In addition, it was found that the fermentation broth of jujube seeds increased the Elastase inhibitory activity as the concentration increased, and the IC 50 was confirmed to be 16.9%. It can be seen that even if only about 16.9% of fermented jujube seed is used, it is very effective in improving wrinkles. It can be seen that Comparative Example 1, which is an ethanol extract of jujube seeds, has no elastase inhibitory activity.
<< 실험예Experimental example 8> 대추씨 8> Jujube seeds 발효물의Fermented 폴리페놀 및 플라보노이드 함량 측정 Determination of polyphenol and flavonoid content
총 폴리페놀 함량은 공인기관에 분석 의뢰하여 「건강기능식품 공전」제 4. 3-64 총 폴리페놀 시험법으로 진행하여 실시예 5와 비교예 1을 하기 표 9에 나타내었다.The total polyphenol content was requested to be analyzed by an authorized institution and proceeded with the "Health Functional Food Code" Article 4. 3-64 Total Polyphenol Test Method, and Example 5 and Comparative Example 1 are shown in Table 9 below.
총 플라보노이드 함량은 공인기관에 분석 의뢰하여 「건강기능식품 공전」Ⅲ.3.6.3 총 플라보노이드 시험법으로 진행하여 하기 표 10에 나타내었다. 플라보노이드는 C6-C3-C6를 기본골격으로 담황색 내지는 노란색을 띠고 있는 페놀계 화합물의 총칭으로, 자연계에 널리 분포하고, 활성산소종을 효과적으로 제거하여 항산화능이 높으며, 항바이러스, 항염증 효과가 있는 것으로 알려져있다. 채소류 이상의 고등식물과 일부 녹조류만이 합성하고 동물은 합성능력이 없어 식물에만 존재하며, 채소류와 유관속 식물의 잎, 꽃, 과실, 줄기, 뿌리 등 거의 모든 부위에 존재하고 있는 것으로 알려져 있다. 플라보노이드는 flavonol계의 quercetin, kaempferol, myricetin이 있으며, flavone계의 apigenin, luteolin 그리고 limonin, momilin 등이 알려져 있다. 그리고 플라보노이드 중에서 quercetin 등은 in vitro에서 low-density lipoprotein(LDL)의 산화와 cytotoxicity를 억제할 수 있다고 알려져 있다.The total flavonoid content was requested to be analyzed by an accredited institution and proceeded with the "Health Functional Food Code" III.3.6.3 Total Flavonoid Test Method, and is shown in Table 10 below. Flavonoids are a generic term for phenolic compounds that have a pale yellow or yellow color with C 6 -C 3 -C 6 as a basic skeleton, and are widely distributed in nature, have high antioxidant activity by effectively removing reactive oxygen species, and have antiviral and anti-inflammatory effects. It is known that there are. It is known that only higher plants than vegetables and some green algae are synthesized, and animals have no synthetic ability, so they exist only in plants, and are known to exist in almost all parts such as leaves, flowers, fruits, stems, and roots of vegetables and related plants. Flavonoids include flavonol-based quercetin, kaempferol, and myricetin, and flavone-based apigenin, luteolin, limonin, and momilin are known. And, among flavonoids, quercetin is known to inhibit the oxidation and cytotoxicity of low-density lipoprotein (LDL) in vitro.
이상에서 본 출원을 바람직한 실시예 및 실험예를 들어 상세하게 설명하였으나, 본 출원은 상기 실시예 및 실험예에 의해 한정되지 않고, 본 출원의 기술적 사상 및 범위 내에서 당 분야에서 통상의 지식을 가진 자에 의하여 여러 가지 변형 및 변경이 가능하다.In the above, the present application has been described in detail with reference to preferred embodiments and experimental examples, but the present application is not limited to the above embodiments and experimental examples, and those having ordinary knowledge in the art within the spirit and scope of the present application Various modifications and changes are possible by the user.
본 출원이 속한 분야에서 통상의 지식을 가진 자라면 상기 내용을 바탕으로 본 발명의 범주 내에서 다양한 응용 및 변형을 행하는 것이 가능할 것이다.Those of ordinary skill in the field to which the present application belongs will be able to perform various applications and modifications within the scope of the present invention based on the above contents.
이상으로 본 출원의 특정한 부분을 상세히 기술하였는 바, 당업계의 통상의 지식을 가진 자에게 있어서 이러한 구체적인 기술은 단지 바람직한 구현예일 뿐이며, 이에 본 출원의 범위가 제한되는 것이 아닌 점은 명백하다. 따라서, 본 출원의 실질적인 범위는 첨부된 청구항과 그의 등가물에 의하여 정의된다고 할 것이다.As described above, a specific part of the present application has been described in detail, and it is clear that this specific technology is only a preferred embodiment for those of ordinary skill in the art, and the scope of the present application is not limited thereto. Accordingly, it will be said that the substantial scope of the present application is defined by the appended claims and their equivalents.
Claims (6)
대추씨 분말을 멸균한 후 유산균, 효모 또는 고초균을 접종하여 발효하여 대추씨 발효물을 수득하는 단계; 및
대추씨 발효물을 멸균한 후 불순물을 제거하는 단계;를 포함하는 대추씨 발효물의 제조방법.Separating and pulverizing the seeds from the jujube;
Sterilizing the jujube seed powder and then inoculating the lactic acid bacteria, yeast or Bacillus into fermentation to obtain a fermented jujube seed; And
A method for producing a fermented jujube seed comprising a; step of removing impurities after sterilizing the fermented jujube seed.
상기 분말화하는 단계는,
동결건조, 열풍건조 또는 자연건조하여 분쇄하거나,
냉장 또는 냉동 보관 후 분쇄하거나 파쇄하여 분말화하는 것을 특징으로 하는 대추씨 발효물의 제조방법.The method according to claim 1,
The powdering step,
Freeze drying, hot air drying or natural drying to crush, or
A method for producing fermented jujube seeds, characterized in that pulverized or crushed to powder after refrigerated or frozen storage.
상기 유산균, 효모 또는 고초균은,
락토바실러스 플란타륨(Lactobacillus plantarum), 바실러스 서브틸리스(Bacillus subtilis), 류코노스톡 메센테로이드(Leuconostoc mesenteroide) 또는 사카로미세스 세레비시아에(Saccharomyces cerevisiae)인 것을 특징으로 하는 대추씨 발효물의 제조방법.The method according to claim 1,
The lactic acid bacteria, yeast or Bacillus bacillus,
Lactobacillus plantarum , Bacillus subtilis , Leuconostoc mecentroid mesenteroide ) or Saccharomyces cerevisiae (Saccharomyces cerevisiae).
상기 발효물을 수득하는 단계에서,
대추씨 분말과 배지를 1:4 내지 1:20의 중량비로 혼합한 후 멸균하고,
100 rpm 내지 300 rpm, 20℃ 내지 45℃에서 1일 내지 10일 동안 배양함으로써 발효가 수행되는 것을 특징으로 하는 대추씨 발효물의 제조방법.The method according to claim 1,
In the step of obtaining the fermented product,
After mixing the jujube seed powder and the medium in a weight ratio of 1:4 to 1:20, sterilized,
Method for producing a fermented jujube seed, characterized in that the fermentation is carried out by culturing for 1 to 10 days at 100 rpm to 300 rpm, 20 to 45 ℃.
상기 불순물을 제거하는 단계는,
발효물을 0.3 ㎛ 내지 5 ㎛ 크기로 여과하거나, 원심분리하여 수행하는 것을 특징으로 하는 대추씨 발효물의 제조방법.The method according to claim 1,
The step of removing the impurities,
A method for producing a fermented jujube seed, characterized in that the fermented product is filtered or centrifuged to a size of 0.3 µm to 5 µm.
상기 멸균은 100℃ 내지 140℃에서 10분 내지 30분 동안 수행되는 것을 특징으로 하는 대추씨 발효물의 제조방법. The method according to claim 1,
The sterilization method for producing fermented jujube seeds, characterized in that performed for 10 to 30 minutes at 100 ℃ to 140 ℃.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190127803A KR102355143B1 (en) | 2019-10-15 | 2019-10-15 | Method for preparing fermentated ziziphus jujuba seed |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190127803A KR102355143B1 (en) | 2019-10-15 | 2019-10-15 | Method for preparing fermentated ziziphus jujuba seed |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20210045529A true KR20210045529A (en) | 2021-04-27 |
KR102355143B1 KR102355143B1 (en) | 2022-01-27 |
Family
ID=75725956
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020190127803A KR102355143B1 (en) | 2019-10-15 | 2019-10-15 | Method for preparing fermentated ziziphus jujuba seed |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102355143B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113559130A (en) * | 2021-07-30 | 2021-10-29 | 湖北真福医药有限公司 | Spina date seed and bacillus subtilis co-fermentation product and preparation method and application thereof |
CN116369387A (en) * | 2023-03-09 | 2023-07-04 | 山西中医药大学 | Wild jujube hericium erinaceus cheese capable of improving sleep and enhancing immunity as well as preparation method and application thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20090111719A (en) * | 2008-04-22 | 2009-10-27 | (주)더페이스샵코리아 | Cosmetic Compositions for whitening Skin containing jujube culture |
KR20180014272A (en) * | 2016-07-28 | 2018-02-08 | 안동대학교 산학협력단 | Composition for skin whitening or anti-inflammatory comprising Zizyphus jujube seed extract as effective component |
-
2019
- 2019-10-15 KR KR1020190127803A patent/KR102355143B1/en active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20090111719A (en) * | 2008-04-22 | 2009-10-27 | (주)더페이스샵코리아 | Cosmetic Compositions for whitening Skin containing jujube culture |
KR20180014272A (en) * | 2016-07-28 | 2018-02-08 | 안동대학교 산학협력단 | Composition for skin whitening or anti-inflammatory comprising Zizyphus jujube seed extract as effective component |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113559130A (en) * | 2021-07-30 | 2021-10-29 | 湖北真福医药有限公司 | Spina date seed and bacillus subtilis co-fermentation product and preparation method and application thereof |
CN116369387A (en) * | 2023-03-09 | 2023-07-04 | 山西中医药大学 | Wild jujube hericium erinaceus cheese capable of improving sleep and enhancing immunity as well as preparation method and application thereof |
CN116369387B (en) * | 2023-03-09 | 2023-12-22 | 山西中医药大学 | Wild jujube hericium erinaceus cheese capable of improving sleep and enhancing immunity as well as preparation method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
KR102355143B1 (en) | 2022-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20110098124A (en) | Composition containing ginseng berry extract using processing of herbal medicine | |
JP2007099625A (en) | Skin fibroblast growth promoter | |
KR101973639B1 (en) | Composition for anti oxidation containing extract of soybean leaf | |
KR20150050310A (en) | Composition for improving skin conditions comprising artemisiae annuae herba, neem leaf, centella asiatica and green tea extract or fraction thereof and method for improving skin conditions using the same | |
KR101821024B1 (en) | COMPOSITION OF SKIN WHITENING CONTAINING EXTRACT OF Gloiopeltis Furcata AND METHOD OF MAKING THE SAME | |
JP2017214349A (en) | Cosmetic and Oral Composition | |
KR101292837B1 (en) | Composition for skin wrinkle improvement comprising extracts of Junglans mandshurica MAXIM as an active ingredient | |
KR102355143B1 (en) | Method for preparing fermentated ziziphus jujuba seed | |
KR20190061544A (en) | Cosmetic Composition for Anti-oxidation and Whitening comprising fermented silkworm extract as effective component | |
KR102014312B1 (en) | Skin-whitening functional composition including polyopes affinis extracts | |
KR102453568B1 (en) | Composition for moisturizing and anti-inflammation comprising fermented Codium fragile extract fermented by inoculating Bacillus safensis strain | |
KR102471009B1 (en) | Cosmetic composition containing Albiggia kalkora extract for skin whitening and improving wrinkles | |
KR20190036975A (en) | Compositions for Improving Skin Wrinkles and Skin Whitening Using an Extract of Polygonum japonica | |
KR20230054129A (en) | Antioxidant, skin whitening and skin wrinkle improvement composition | |
KR102154139B1 (en) | Composition comprising fermentation of sap of painted maple, cacao nibs extract and granat extract | |
KR102090169B1 (en) | Cosmetic composition for anti-wrinkle and enhancing elasticity comprising fermented extract of Angelica tenuissima | |
KR101995384B1 (en) | Composition for skin whitening and anti-oxidation comprising fermented Gynura procumbens as effective component | |
KR102355138B1 (en) | Composition for whitening or anti-wrinkle of the skin comprising fermentated ziziphus jujuba seed as effective component | |
KR102058022B1 (en) | Composition for antioxidant and anti-inflammatory comprising fraction of Ledum palustre L. extract as effective component | |
KR20120050059A (en) | Composition for skin wrinkle improvement and whitening comprising extracts of coriandum sativum. l as an active ingredient | |
JP4902967B2 (en) | Melanin production inhibitor | |
CN113631227A (en) | Antiaging agent, antioxidant, antiinflammatory agent, whitening agent, and cosmetic | |
KR102401490B1 (en) | Compositions containing Angelica gigas extract | |
KR101563230B1 (en) | A method of preparing extract improving anti-oxidative activity | |
KR20140086214A (en) | The method for manufacturing panax ginseng composite by using the punica granatum concentrate for skin whitening, and the panax ginseng composite made by the method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right |